Zacks Investment Research on MSN
SENS Stock Up as Eversense 365 Enters AID Market With twiist System
Senseonics Holdings, Inc. SENS recently reached an important commercialization milestone with the launch of its Eversense 365 ...
ViCentra is expanding production and international operations while advancing its Kaleido insulin patch pump to support ...
You can be misdiagnosed with type 2 diabetes instead of another type of the condition, because some symptoms may be similar, ...
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...
8don MSN
2026 New California laws | Insulin out-of-pocket costs capped, step therapy requirements prohibited
Insulin costs have tripled over the past decade, with most of the increase going to middlemen and corporations.
Scientists inch closer to an autologous diabetes cell therapy that dodges the challenge of immune rejection, creating insulin-producing cells from the lining of the gut. As of 2025, an estimated 9.5 ...
Introduction Psychological barriers to insulin therapy are associated with the delay of clinically indicated treatment intensification for people with type 2 diabetes (T2D), yet few evidence-based ...
Infusion therapy delivers medicine directly into the bloodstream because some people can't take medicine by mouth. Infusion therapy can be done in a medical setting or at home, like with insulin shots ...
The t:slim X2 automated insulin delivery system with Control IQ+ technology. [Image courtesy of Tandem Diabetes Care] Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received approval to ...
The FDA has approved Kirsty, the first interchangeable insulin aspart biosimilar, enhancing access to affordable diabetes care for millions. The FDA has announced a significant advancement in diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results